More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer

publications Trending Topics & Drug Approvals: November 2025 Your source for the latest drug information highlights November 4, 2025 Trending Topics Drug Approvals Trending Topics Hot topics The...

Power your success with combined pharmacy and medical data Integrated data. Actionable insights. Pharmacist outreach. All in one innovative product. Breadcrumb Home Our solutions Clinical...

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

Read Drug Approvals Monthly Update: January 2024 Critical updates in an ever-changing environment. Drug Approval Update Specialty New drugs 12/22/2023 Wainua™ (eplontersen) The United States (U.S.)...

Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.

Read Drug Approvals Monthly Update: February 2024 This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news...

publications High-Cost Therapy Profile: March 2025 Pegzilarginase Intravenous (IV), Subcutaneous (SC) | Immedica Metabolic March 14, 2025 Proposed indications Arginase 1 deficiency (ARG1-D)...